On the contrary, M2 macrophages can provide a nutritional advantage to cancer cells when stimulated by IL-4, IL-6, IL-10, IL-13, transforming growth factor β (TGF-β), vascular endothelial growth factor (VEGF) and other M2-specific cytokines [34, 38, 39]. This evidence concerns the gene IL6 and cancer.